| 25 May 2026 |
PTD-DBM |
8.9 |
5mg |
5.6mg |
+12.1% |
97.82% |
Lab E |
| 25 May 2026 |
Trenbolone Acetate |
4.3 |
200mg/ml |
235.7mg/ml |
+17.9% |
98.58% |
Lab B |
| 25 May 2026 |
YK11 |
8.7 |
100mg |
98.0mg |
-2.0% |
95.61% |
Lab F |
| 24 May 2026 |
Drostanolone Propionate (Mast P) Raw |
4.5 |
1g |
1.2g |
+21.0% |
97.12% |
Lab B |
| 24 May 2026 |
BMK methyl glycidate CAS 80532-66-7 |
4.3 |
100g |
89.5g |
-10.5% |
96.22% |
Lab D |
| 24 May 2026 |
Crystagen |
4.0 |
2mg |
1.7mg |
-12.9% |
97.91% |
Lab C |
| 24 May 2026 |
NA Semax Amidate |
5.1 |
5mg |
5.4mg |
+7.4% |
97.18% |
Lab A |
| 23 May 2026 |
GHRP-6 Acetate |
7.4 |
5mg |
5.7mg |
+13.7% |
97.16% |
Lab D |
| 23 May 2026 |
Vilon |
6.7 |
10mg |
11.4mg |
+13.7% |
97.87% |
Lab B |
| 23 May 2026 |
BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 |
6.2 |
500g |
504.2g |
+0.8% |
98.90% |
Lab D |
| 21 May 2026 |
BPC157 5mg + TB500 5mg Blend |
4.0 |
2mg |
2.3mg |
+13.4% |
97.35% |
Lab A |
| 21 May 2026 |
Glutathione |
6.2 |
30mg |
30.3mg |
+0.9% |
96.41% |
Lab A |
| 21 May 2026 |
Letrozole |
7.9 |
20mg |
21.3mg |
+6.4% |
97.91% |
Lab A |
| 20 May 2026 |
IGF-1 LR3 |
4.0 |
15mg |
12.8mg |
-14.4% |
97.10% |
Lab E |
| 19 May 2026 |
N-Acetyl Epitalon Amidate |
10.0 |
30mg |
32.5mg |
+8.3% |
99.05% |
Lab D |
| 17 May 2026 |
ACE-031 |
6.9 |
30mg |
31.0mg |
+3.5% |
97.75% |
Lab D |
| 17 May 2026 |
AICAR |
4.0 |
10mg |
11.3mg |
+13.2% |
98.67% |
Lab A |
| 17 May 2026 |
KissPeptin-10 |
4.1 |
5mg |
5.7mg |
+14.0% |
95.44% |
Lab C |
| 29 Jan 2026 |
Testosterone Cypionate Raw |
5.3 |
500g |
473.8g |
-5.2% |
98.60% |
Lab B |
| 9 Jan 2026 |
PMK methyl glycidate CAS 1369021-80-6 |
6.0 |
100g |
124.1g |
+24.1% |
98.34% |
Lab B |
| 7 Jan 2026 |
Anastrozole (Arimidex) Raw |
5.2 |
5g |
4.6g |
-7.7% |
97.36% |
Lab A |
| 7 Jan 2026 |
BPC-157 Arg Oral |
4.0 |
20mg |
20.7mg |
+3.3% |
96.29% |
Lab E |
| 7 Jan 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
5.5 |
30mg |
29.3mg |
-2.3% |
95.63% |
Lab E |
| 7 Jan 2026 |
Lipo-B 216mg |
4.7 |
250mg/ml |
277.8mg/ml |
+11.1% |
97.82% |
Lab A |
| 7 Jan 2026 |
Salbutamol |
5.3 |
20mg |
19.4mg |
-2.9% |
98.33% |
Lab A |
| 6 Jan 2026 |
Methylene Blue |
4.0 |
10mg |
10.4mg |
+3.8% |
99.19% |
Lab B |
| 6 Jan 2026 |
NAD+ Injectable |
6.1 |
100mg/ml |
97.7mg/ml |
-2.3% |
96.05% |
Lab E |
| 5 Dec 2025 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
9.3 |
10mg |
9.7mg |
-3.4% |
97.90% |
Lab C |
| 5 Dec 2025 |
Semaglutide Raw |
9.1 |
10g |
11.3g |
+13.3% |
98.03% |
Lab A |
| 5 Nov 2025 |
SNAP-8 |
6.9 |
5mg |
5.6mg |
+11.8% |
97.37% |
Lab A |
| 4 Nov 2025 |
BAC Water |
5.9 |
50mg |
45.2mg |
-9.6% |
96.06% |
Lab D |
| 17 Oct 2025 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
6.8 |
30mg |
35.5mg |
+18.3% |
98.98% |
Lab C |
| 17 Oct 2025 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
6.4 |
2mg |
2.2mg |
+10.3% |
95.81% |
Lab F |
| 9 Oct 2025 |
Test Enanthate |
5.1 |
200mg/ml |
189.7mg/ml |
-5.2% |
99.73% |
Lab G |
| 21 May 2025 |
Tirzepatide |
|
6.5 |
10mg |
8.63mg |
-13.7% |
White Label / Silver Crimp / Blue Cap |
| 21 May 2025 |
Melanotan II |
|
4.8 |
10mg |
4.76mg |
-52.4% |
White Label / Silver Crimp / Yellow Cap |
| 21 May 2025 |
Tirzepatide |
|
7.6 |
10mg |
9.3mg |
-7.0% |
White Label / Silver Crimp / Blue Cap |
| 21 May 2025 |
Melanotan II |
|
4.8 |
10mg |
4.43mg |
-55.7% |
White Label / Silver Crimp / Yellow Cap |
| 7 May 2025 |
PT-141 |
|
7.2 |
10mg |
8.15mg |
-18.5% |
White Label / Silver Crimp / Blue Cap |
| 7 May 2025 |
CJC-1295 |
DAC |
2.9 |
10mg |
1.16mg |
-88.4% |
White Label / Copper Crimp / Clear Cap |
| 7 May 2025 |
CJC-1295 |
DAC |
2.9 |
10mg |
1.1mg |
-89.0% |
White Label / Copper Crimp / Clear Cap |